Efficacy of dupilumab for the treatment of severe skin disease in cytotoxic T lymphocyte antigen-4 insufficiency: A role of type 2 inflammation?
Titel:
Efficacy of dupilumab for the treatment of severe skin disease in cytotoxic T lymphocyte antigen-4 insufficiency: A role of type 2 inflammation?
Auteur:
Arruda, L. Karla Cordeiro, Daniel L. Langer, Sarah S. Koenigham-Santos, Marcel Calado, Rodrigo T. Dias, Marina M. Anhesini, Leonardo R. Oliveira, João Bosco Grimbacher, Bodo Ferriani, Mariana P.L.